Status:
COMPLETED
Validation of BodPod in Pediatric Anorexia Nervosa
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Anorexia Nervosa
Eligibility:
FEMALE
8-18 years
Phase:
NA
Brief Summary
Anorexia nervosa is a severe cause of undernutrition. It leads to a dramatic decrease of weight with an important modification of the body composition. During the renutrition phase, disharmonious body...
Eligibility Criteria
Inclusion
- Female patients aged between 8 and 18 years
- Female with a diagnosis of anorexia nervosa according to the DSM V classification, restrictive type or hyperphagic / purgative access type, evolving for less than 3 years.
- Female who received explanations adapted to their level of understanding for this study
- Female who expressed their consent to participate to this study
- Female whose parents or holders of parental authority have been informed and signed free and informed consent
- Female affiliated to a social security scheme
Exclusion
- Patients with psychotic symptoms
- Patients with claustrophobia
- Patients with severe respiratory disease
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04321317
Start Date
April 19 2021
End Date
March 1 2023
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre REférent pour l'Anorexie et les Troubles du Comportement Alimentaire de Lyon (CREATyon) - Hôpital Neurologique Pierre Wertheimer - Hospices Civils de Lyon
Bron, France, 69677